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Background 
Experimental and clinical investigations suggest that reperfusion is considered ‘a double-
edged sword’, as reperfusion would restore oxygen and nutrients supply to the ischemic 
myocardium to improve its functional recovery, but in the other hand reperfusion could 
augment myocardial ischemic damage, known as myocardial ischemia-reperfusion (I/R) 
injury. The brief and repeated cycles of I/R given at a distant organ before a sustained 
ischemia and reperfusion, known as remote ischemic preconditioning (RIPC), would protect 
the heart from lethal I/R injury.  
Objective 
The effect of ischemic preconditioning in a diabetic heart is a contradictory whether it could 
improve or worsen the damage degree of myocardial  I/R injury, as reported by some 
previous studies. These inconsistent reports need further studies. 
Methods 
Twenty-four diabetic patients with stable CAD undergoing elective percutaneus coronary 
intervention were randomly assigned to 2 groups: 14 patients submitted to RIPC and 10 
patients were control group. We induced RIPC by inflating a blood pressure cuff placed on 
the upper limb to 20 mmHg above systolic arterial pressure for 5 min and deflating the cuff 
for 5 min; 4 cycles were performed. All patients had CK-MB level measured at baseline and 
18-24 hours after the elective PCI. Myocardial injury was considered when post-PCI CK-MB 
level rose up to 1-3 fold of the upper normal limit. 
Results 
A higher proportion in control group (40%) experienced myocardial injury, compared with 
the group receiving RIPC (0%) (p = 0.02). The mean of baseline CK-MB was equal in both 
control and RIPC groups (19.07 ± 2.84 and 17.5 ± 2.32, respectively; p = 0.165). While the 
mean of post-PCI CK-MB level in two groups differed significantly (34.2 ± 10.43 and 24.42 
± 4.03, respectively; p = 0.017). 
 
Conclusions 
RIPC lower the incidence of myocardial injury in diabetic patients after elective percutaneus 
coronary intervention. These data suggest that diabetic patients still gain protection of RIPC. 
 
Introduction 
The strategy of reperfusion of ischemic myocardium in patients with coronary artery 
disease has led to a significant improvement of outcomes. However, reperfusion after a 
prolonged period of ischemia damages the myocardium, through a process known as 
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ischemia/reperfusion injury (I/R)
1
.
 
Transient sublethal episodes of ischemia before a 
prolonged I/R injury, known as ischemic preconditioning (IPC), have been shown to reduce 
the extent of myocardial infarction (MI). This protection not only acts locally but also can 
protect distant tissues, a phenomenon known as remote IPC (RIPC), and limits myocardial 
infarction size in animal models
2
.
  
In humans, RIPC protects against endothelial I/R injury
3
 
and the extent of MI after adult coronary bypass surgery, pediatric surgery, and noncardiac 
surgery
4
. 
Chronic diabetes mellitus remains one of root causes of mortality in developed as well 
as developing countries with towering prevalence. It has been stated that 23.5 million adults 
of 20 years or older have had a diagnosis of both coronary artery disease and diabetes 
mellitus, with an estimation that by 2025, an additional 9% of the total US population will 
have a diagnosis of a combination of these disorders
5
. Studies have demonstrated 
preconditioning-mediated cardioprotection in the diabetic myocardium. Moreover, Tatsumi et 
al.
5
 suggested that the diabetic myocardium could rather benefit more from preconditioning 
stimulus than the normal myocardium, possibly due to diabetes induced reduction in the 
production of glycolytic metabolites during sustained ischemia and concomitant attenuation 
of intracellular acidosis. However, it remains a question whether the diabetic myocardium 
could be protected by the preconditioning stimulus, as considerable numbers of studies 
paradoxically demonstrated no preconditioning mediated cardioprotection in the presence of 
chronic diabetes mellitus. 
  
Materials and Methods 
Twenty-four diabetic patients with stable CAD undergoing elective percutaneus 
coronary intervention, and informed written consent was obtained from each patient. 
Exclusion criteria were patients with pre procedural CK-MB level above normal limit, acute 
ST-elevation myocardial infarction undergoing primary PCI, acute coronary syndrome less 
than 7 days before elective PCI, angina pectoris CCS III within the last 24 hours before 
elective PCI, systolic blood pressure < 90 mmHg, pulmonary oedema or cardiogenic shock, 
significant renal insufficiency (creatinine level > 2.5 mg/dL that may influence blood enzyme 
kinetic), target lesion Chronic Total Occlusion (CTO) more than 3 months, with the presence 
of collateral vessels, symptomatic peripheral arterial disease. The patients were randomly 
assigned to 2 groups: 14 patients submitted to RIPC and 10 patients were control group. 
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Remote ischaemic preconditioning (RIPC) 
We induced RIPC by inflating a blood pressure cuff placed on the upper limb to 20 mmHg 
above systolic arterial pressure for 5 min and deflating the cuff for 5 min; 4 cycles were 
performed, approximately 1 hour before PCI. RIPC was not performed in control group. 
This protocol adapted the study conducted by Rentoukas
1
, which showed the useful role of 
RIPC for the prevention of reperfusion injury  in patients submitted to primary PCI.  
 
Percutaneus Coronary Intervention 
PCI was conducted with the monorail technique and 7F catheters. The selection of coronary 
balloons and stents was left to the discretion of the interventional cardiologist. Coronary 
stents were implanted in all patients of both groups after balloon pre-dilatation of the target 
lesion according to the decision of the operators. All lesions treated were de novo lesions of 
native coronary arteries. 
 
Blood sampling and laboratory measurements 
Venous blood samples for CK-MB level measurements were obtained at baseline and 12-48 
hours after the elective PCI. Serum was obtained by centrifugation at 1000 g for 15 min. CK-
MB concentrations between 7 and 25 U/l were considered to be within the reference range. 
Values are expressed as nanograms per millilitre. Myocardial injury was considered when 
post-PCI CK-MB level rose up to 1-3 fold of the upper normal limit. 
 
Statistical analysis 
All data are expressed as mean. For comparisons between the two main groups, Student’s t 
test (unpaired) was used. Significance was taken at a p value of 0.05. 
 
RESULTS 
1. Baseline characteristic 
 Table 1 shows the baseline epidemiological and clinical features of the groups. There 
were no important differences between the groups. Except for the level of blood glucose, 
which the mean of RIPC group and control group differed significantly (163.7 ± 41.8 and 
124.8 ± 24.5, respectively ; p = 0.015). 
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Table 1. Baseline Epidemiological and Clinical Features of the Study Population 
 RIPC Groups Control Groups p value 
Age, mean ± SD 60.5 ± 5.5 58.1 ± 5.4 0.302 
Male, n (%) 11 (78.6) 7 (70) 0.615 
BMI, mean ± SD 23.6 ± 2.9 23.6  ± 3.1 0.959 
Ejection fraction, mean ± SD 54.5 ± 8.8 53.9 ± 8.8 0.871 
CAD Risk Factors, n (%) 
Hypertension  11 (78.6) 9 (90) 0.437 
Active smoker  2 (14.3) 1 (10) 0.643 
Family history 2 (14.3) 0 (0) 0.332 
Hypercholesterolemia  3 (21.4) 2 (20) 0.668 
Laboratory findings, mean ± SD 
Hb 12.29 ± 1.35 13.54 ± 1.88 0.071 
Leukocyte  9142.14 ± 1341 9028 ± 1751 0.858 
Platelet  270550 ± 69826 259210 ± 78867 0.714 
Ureum  40.7 ± 16.3 30.6 ± 10.6 0.1 
Creatinine  1.3 ± 0.2 1.3 ± 0.2 0.66 
Blood glucose 163.7 ± 41.8 124.8 ± 24.5 0.015 
Total cholesterol 209.7 ± 38.7 188.4 ± 42.5 0.215 
HDL 31.1 ± 4.1 29.7 ± 3.3 0.372 
Triglyceride 133 ± 55.6 122 ± 33.9 0.599 
Medications at enrollment, n (%) 
Beta blockers 6 (42.8) 3 (30) 0.418 
Nitrates  8 (57.1) 7 (70) 0.418 
Statin  13 (92.8) 10 (100) 0.583 
ACE inhibitors 8 (57.1) 7 (70) 0.418 
ARB 12 (85.7) 7 (70) 0.332 
Trimetazidine  12 (85.7) 9 (90) 0.629 
 
2. Angiographic and Interventional Procedure Characteristic 
  No differences were observed between the studied groups in angiographic and 
interventional procedure characteristic in terms of lesion type (ACC/AHA), target vessels, 
stenosis severity, predilatation type, stenting type, and total stent length, as shown in table 2. 
In this study, all patients received DES.  
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Table 2. Angiographic and Interventional Procedure Characteristic 
 RIPC Groups Control Groups p value 
Lesion type (ACC/AHA), n  
A 
B 
C 
 
0 
12 
2 
 
1 
6 
3 
 
0.272 
Target vessels, n 
1 
2  
3 
 
8 
5 
1 
 
5 
3 
2 
 
0.643 
Stenosis severity, %, mean±SD 80.71 ± 6.75 85 ± 8.16 0.174 
Predilatation time, s, mean±SD 71.5 ± 54.5 71.8 ± 53.3 0.989 
Stenting time, s, mean±SD 76.7 ± 50.8 81.6 ± 37.4 0.802 
Total stent length, mm, mean±SD 52.1 ± 26.4 61.5 ± 35.2 0.464 
 
3. Baseline and Post-PCI CK-MB Level  
 Table 3 presents the mean of baseline and post-PCI CK-MB level of the two groups. 
There were no significant differences between groups in baseline levels of CK-MB (19.07 ± 
2.84 and 17.5 ± 2.32, respectively; p = 0.165). While the mean of post-PCI CK-MB level in 
two groups differed significantly (34.2 ± 10.43 and 24.42 ± 4.03, respectively; p = 0.017). A 
higher proportion in control group (40%) experienced myocardial injury, compared with the 
group receiving RIPC (0%) (p = 0.02). 
 
Table 3. Baseline and Post-PCI CK-MB Level 
 RIPC Groups Control Groups p value 
Baseline CK-MB, U/l 19.0 ± 2.8 17.5 ± 2.3 0.165 
Post-PCI CK-MB, U/l 24.4 ± 4.0 34.4 ± 10.4 0.017 
Myocardial Injury, n (%) 0 4 0.02 
 
DISCUSSION 
This study shows that RIPC lower the incidence of myocardial injury in diabetic 
patients after elective percutaneus coronary intervention, as expressed in the mean of baseline 
and post-PCI CK-MB level. This finding was consistent with the study of Zhu et al.
6
 
 JNH, Vol. 3, No.2, Agustus 2015 
conducted in streptozotocin(STZ)-induced diabetic rats. In their study, Zhu et al.
6
 
demonstrated that non-invasive limb IPC ameliorated ventricular arrhythmia, reduced 
myocardial infarct size, increased activities of total superoxide dismutase (SOD), manganese-
SOD and glutathione peroxidase. It is concluded that non-invasive IPC reduces oxidative 
stress and attenuates myocardium ischemia-reperfusion injury. 
The protective action of ischemic post-conditioning has been known for some time. 
One study by Tatsumi et al.
5
 demonstrated cardioprotective effects of IPC (2 cycles of 
ischemia and reperfusion of 5 min each) in STZ-induced diabetic rats against myocardial I/R 
involved preservation of mitochondrial oxidative phosphorylation, inhibition of glycolysis 
during ischemia, and the simultaneous attenuation of intracellular acidosis in the diabetic 
heart explaining the possible mechanisms involved. In addition, Ravingerova et al.
7
 showed 
that STZ-induced chronic diabetic rat hearts could be more benefited from IPC (1 cycle of 5-
min ischemia and 10-min reperfusion) mediated cardioprotection. Interestingly, Tsang et al.
8  
observed cardioprotection by IPC with 3 cycles (5-min global ischemia followed by 10-min 
reperfusion) in Goto-Kakizaki diabetic rat hearts, while IPC with 1 cycle did not have any 
cardioprotective effect. This study suggested that induction of Akt phosphorylation could 
have taken place in multiple cycles of IPC (but not in single cycle of IPC) that could have 
afforded cardioprotection in diabetic rat hearts. In summary, myocardial Akt 
phosphorylation, preservation of mitochondrial oxidative phosphorylation, inhibition of 
glycolysis during ischemia, decreased production of glycolytic metabolites, reduced 
intracellular acidosis and attenuated oxidative stress could be potential mechanisms involved 
in IPC-mediated cardioprotection against I/R injury in the diabetic heart
9, 10
. 
 
 
 
 
 
CONCLUSION 
RIPC lower the incidence of myocardial injury in diabetic patients after elective 
percutaneus coronary intervention. These data suggest that diabetic patients still gain 
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protection of RIPC, possibly due to myocardial Akt phosphorylation, preservation of 
mitochondrial oxidative phosphorylation, inhibition of glycolysis during ischemia, decreased 
production of glycolytic metabolites, reduced intracellular acidosis and attenuated oxidative 
stress. 
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